Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels

Abstract

Circulating sclerostin is increased in T2DM patients with atherosclerotic lesions. Although the sample size of our study was small, these data suggest that sclerostin levels could be a major modulator of Wnt signaling in AD with implications in T2DM patients.